- Home
- BBOT vs CTKB Comparison
BBOT vs CTKB Comparison
Compare BBOT & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BBOT | CTKB |
|---|---|---|
| Founded | 2016 | 1990 |
| Country | United States | United States |
| Employees | 106 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 705.7M | 595.2M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | BBOT | CTKB |
|---|---|---|
| Price | $8.55 | $3.97 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 4 |
| Target Price | ★ $24.00 | $5.63 |
| AVG Volume (30 Days) | 362.8K | ★ 932.5K |
| Earning Date | 05-26-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $193,015,000.00 |
| Revenue This Year | N/A | $5.42 |
| Revenue Next Year | N/A | $7.03 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 17.67 |
| 52 Week Low | $7.60 | $2.43 |
| 52 Week High | $14.87 | $6.18 |
Technical Indicators
Market Signals| Indicator | BBOT | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 49.24 | 45.61 |
| Support Level | $8.08 | $3.30 |
| Resistance Level | $9.73 | $4.26 |
| Average True Range (ATR) | 0.57 | 0.30 |
| MACD | 0.11 | -0.03 |
| Stochastic Oscillator | 59.04 | 40.77 |
Price Performance
Historical ComparisonAbout BBOT BridgeBio Oncology Therapeutics Inc.
BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.
About CTKB Cytek Biosciences Inc.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.